1 July 2024
Latham & Watkins Advises Lifecore Biomedical on Cooperation Agreement With 22NW
Advising firms
Deal team
11 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Christopher Drewry Lead | Latham & Watkins LLP | Partner | Shareholder Activism & Takeover Defense | Chicago |
| Tessa Bernhardt | Latham & Watkins LLP | Partner | Shareholder Activism & Takeover Defense | Bay Area |
| Darren Guttenberg | Latham & Watkins LLP | Partner | Shareholder Activism & Takeover Defense | Orange County |
| Michele Anderson | Latham & Watkins LLP | Partner | Shareholder Activism & Takeover Defense | Washington, D.C. |
| Jack Vanderford | Latham & Watkins LLP | Associate | Shareholder Activism & Takeover Defense | Not stated |
| Kennedy Holmes | Latham & Watkins LLP | Associate | Shareholder Activism & Takeover Defense | Not stated |
| Manny Abascal | Latham & Watkins LLP | Partner | litigation | Los Angeles |
| Scott Westhoff | Latham & Watkins LLP | Partner | capital markets | Chicago |
| Greer Gaddie | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Chelsea Carlson | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Brian Miller | Latham & Watkins LLP | Partner | securities | Washington, D.C. |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Lifecore Biomedical, Inc.Other
- Counterparties
- 22NW, LP (Other)
Legion Partners Asset Management, LLC (Other)
Wynnefield Capital, Inc. (Other)